Trial for Treatment Refractory Trigeminal Neuralgia

Summary

The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater reduction in the average Numeric Pain Rating Scale between the two-week treatment phases.

Timeline

Start

2019-06-25

Primary completion

2023-05-11

Completion

2023-05-11

Drugs

Indications